New wound treatment enters first human safety tests
NCT ID NCT07379684
Summary
This early-stage study is testing the safety of Amicidin-β, a liquid solution applied directly into infected surgical or traumatic wounds during standard surgical procedures. Researchers will enroll 44 adults with wound infections to compare standard care alone versus standard care plus the experimental solution. The main goal is to determine if the treatment is safe enough for larger trials and whether it gets absorbed into the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL WOUND INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
LifeBridge Health
RECRUITINGBaltimore, Maryland, 21215, United States
-
Snake River Research, PLLC
RECRUITINGIdaho Falls, Idaho, 83404, United States
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.